KKR-backed Capsugel, a company that manufactures and sells drug capsules, acquired Xcelience and Powdersize, two US dosage forms companies. Financial terms were not disclosed. "The additions of Xcelience and Powdersize accelerate Capsugel's strategy to expand our service offerings through continued investments in new capabilities and technologies,” said Guido Driesen, President and CEO of Capsugel. "The expertise and high levels of service that we gain in this transaction will make us an even stronger, more-differentiated partner as we collaborate with pharmaceutical companies to bring better medicines to patients."